Longevity Telehealth Pricing Index

Direct answer

The RightFit Longevity Telehealth Pricing Index now includes a broader mix of prescription longevity and wellness programs, including NAD+, sermorelin, glutathione, MIC+B12, metformin, rapamycin, tadalafil, and related clinician-guided programs. AgelessRx adds several new market benchmarks alongside existing providers. RightFit keeps route, formulation, preparation type, billing term, commitment, and included services attached to each price observation rather than treating longevity as one interchangeable category.

Current NAD+ market snapshot

NAD+ has one of the broadest current longevity datasets in RightFit because providers advertise several routes, including compounded injections, nasal sprays, and oral formulations. Those routes remain separate in the underlying records. A nasal-spray price is not used as the cost of an injection program, and an oral amount is not treated as interchangeable with either route.

Current sermorelin market snapshot

Current sermorelin telehealth programs are primarily compounded injections, with at least one tracked orally dissolving formulation. RightFit keeps normal recurring prices, multi-month effective rates, separate memberships, shipping inclusions, and quarterly or prepaid structures as distinct fields so the smallest monthly-looking number does not erase the commitment required to obtain it.

Current glutathione market snapshot

Glutathione providers currently use several recurring and multi-month pricing models. The index treats the provider’s commercial offer as the source fact while keeping wellness claims outside the price comparison.

Current MIC+B12 market snapshot

MIC+B12 and other lipotropic programs can be sold as compounded injections with different supply sizes and commitment terms. RightFit keeps the exact formulation and provider source with the price rather than merging every product described with terms such as lipotropic, Lipo-B, Lipo-C, or MIC+B12 into one generic offer.

Why the index stays formulation-specific

Longevity marketing often groups very different products under one broad category. That is useful for browsing, but it is not precise enough for price analysis. An injectable peptide, a compounded NAD+ nasal spray, an antioxidant injection, and a lipotropic blend can have different ingredients, routes, supply formats, billing terms, and regulatory context.

RightFit therefore calculates and displays treatment summaries from the structured provider-treatment records rather than treating the longevity category itself as one priceable product. The category helps organize the market; the formulation remains the unit that makes a price meaningful.

Normal prices and discounted monthly equivalents are kept separate

Several current longevity providers publish one-month pricing alongside lower effective monthly amounts for three-, six-, or twelve-month purchases. Amble and Effecty are clear examples of this structure across multiple longevity products. A lower twelve-month equivalent can be useful for comparison, but it requires a different financial commitment from true month-to-month billing.

The index therefore keeps the normal recurring observation and the term-dependent observation as separate records. A long-term promotional rate does not overwrite the ordinary monthly price merely because it is lower.

Product-specific pages take priority over broad homepage teasers

A provider can display a broad starting price on its homepage while its dedicated treatment page lists the actual plan ladder. When those pages differ, RightFit gives more weight to the current product-specific page for that exact treatment and keeps the broader teaser as marketing context rather than the canonical treatment price.

This source hierarchy is especially important in longevity catalogs because providers frequently run landing-page promotions, coupon campaigns, or category-level starting-price messages at the same time as their ordinary product pricing.

Provider landing pages can introduce temporary promotions

A provider can maintain a standard treatment catalog while also publishing treatment-specific landing pages with first-order discounts. RightFit should not silently replace the normal recurring price with a coupon-adjusted first order. The promotional amount belongs in a conditional price record with its eligibility language whenever the evidence is clear enough.

The same principle applies to any provider: an introductory code, limited-time discount, first-month rate, or affiliate campaign should remain distinct from the standard commercial offer.

What the index counts

• Published provider-treatment programs with a current source.
• Published normal and conditional price observations.
• The exact treatment and formulation attached to each program.
• Billing period and supply duration when published.
• Multi-month commitment or prepaid eligibility when published.
• Separate membership or program fees when verified.
• Shipping, clinician-access, consultation, or lab inclusions only when the provider states them.
• The source and last-verification date.

What the index does not count as the same thing

• Different routes are not merged just because they share a treatment name.
• A promotional first order is not treated as the standard recurring price.
• A monthly equivalent is not treated as proof of monthly billing.
• A separate membership is not hidden inside the medication amount.
• An unverified lab or shipping charge is not converted to zero.
• Provider wellness claims are not used to increase or decrease a price score.
• A broad homepage starting price is not automatically substituted for a more specific product-page price.

Why medians need context

A market median can be useful, but its meaning depends on which observations are included. Combining normal prices with twelve-month effective rates can pull the number downward. Combining injections with nasal or oral products can mix unlike formulations. RightFit therefore treats summary statistics as descriptive views of the verified dataset, not as one universal fair price.

When a treatment has enough observations, a better analysis can segment by route, preparation type, price kind, or commitment. The live structured data makes that possible without rewriting the editorial explanation every time a provider changes price.

The amount due today can matter more than the monthly equivalent

A longevity program advertised at a low effective monthly rate can require substantially more money up front for a multi-month term. Another program can have a higher monthly rate but allow true month-to-month billing. The index preserves both structures rather than declaring the lower normalized figure automatically cheaper for every shopper.

Memberships and care fees can change the practical recurring total

Some longevity providers include clinical evaluation, ongoing messaging, shipping, or supplies in the displayed medication price. Others charge a separate membership or subscription. RightFit stores those required fees separately so the provider’s medication amount remains auditable while the broader recurring obligation can still be understood.

Shipping is common but still needs verification

Many current longevity programs explicitly include delivery. RightFit records shipping as included only when the provider source says so. A silent page remains unknown, and an included-shipping flag is not converted into a quality claim about speed, temperature control, or replacement policies.

Regulatory status stays attached to the product

Many products in the current longevity dataset are compounded prescription formulations. Compounded status is preserved at the formulation level. RightFit does not describe a compounded product as FDA-approved simply because an ingredient has appeared in another approved product or because the provider uses clinical-sounding wellness language.

Provider claims and the price index serve different purposes

Longevity treatment pages frequently market energy, recovery, sleep, performance, skin, metabolism, or healthy-aging outcomes. Those claims may explain why a provider markets the product, but they are not variables in RightFit’s price index. The index compares commercial facts; clinical claims require their own evidence review.

Why verification dates matter

Longevity catalogs can change quickly. Providers add formulations, alter supply terms, change plan lengths, create landing-page promotions, or revise what is included. RightFit keeps a verification date with the underlying source so the index can be refreshed without treating one captured price as permanent.

When a current first-party source conflicts with another current first-party page, the safer approach is to preserve the conflict for review or identify the pages as different commercial offers. RightFit does not choose the lower number simply because it is more attractive.

How to use the index

• Start with the exact treatment rather than the broad longevity category.
• Check formulation and route before comparing prices.
• Separate normal recurring pricing from prepaid or promotional rates.
• Look at the amount and term billed, not only the monthly equivalent.
• Add verified required membership or care fees.
• Check whether shipping and clinician access are included.
• Use program-level state availability when it has been verified.
• Review the source date before treating the displayed amount as current.

What the index cannot decide

The pricing index cannot determine whether a longevity treatment is appropriate for an individual, whether one route is better than another for that person, whether a provider’s advertised wellness outcomes are supported, or whether the lowest-priced program represents the best medical value. Those questions are outside a public-price dataset.

Bottom line

The RightFit Longevity Telehealth Pricing Index is designed to make a fragmented market easier to inspect without flattening the differences that make prices meaningful. Current tracked programs now span NAD+, sermorelin, glutathione, MIC+B12, metformin, rapamycin, tadalafil, and other longevity offerings. By keeping formulation, route, commitment, fees, and provider-primary sources attached to each record, RightFit can expand coverage without turning price into a clinical ranking.

Why missing fields are not treated as zero

A provider can publish a treatment price without clearly stating labs, cancellation details, state coverage, or every included service. RightFit leaves those fields unknown until a current source supports them. That prevents an incomplete provider page from making a program appear artificially cheaper or more inclusive than the evidence allows.